STAT3 and liver cancer: Several studies have demonstrated that CDK5 activity modulates the signal transducer and activator of transcription 3 (STAT3) protein through Ser-727 phosphorylation in neurons [93,94], head and neck squamous cell carcinoma [95], and liver cancer cells [96].